Bone changes in early inflammatory arthritis assessed with High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT): A 12-month cohort study.

Bone erosions Bone mineral density Early inflammatory arthritis High resolution peripheral quantitative computed tomography (HR-pQCT) Rheumatoid arthritis

Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
01 2021
Historique:
received: 03 03 2020
accepted: 21 07 2020
pubmed: 9 9 2020
medline: 29 6 2021
entrez: 8 9 2020
Statut: ppublish

Résumé

Erosion development is of crucial significance as it impacts prognosis and therapy decisions in patients with inflammatory joint diseases. Our study aimed to determine the sensitivity of high-resolution peripheral quantitative computed tomography (HR-pQCT) to detect change of bone surface over time and to identify erosion development in early inflammatory arthritis (EIA) patients. Moreover, the contribution of prognostic factors on periarticular bone damage in the first year of diagnosis assessed by HR-pQCT was explored. 46 patients with arthritic symptoms for less than one year, and a clinical diagnosis of inflammatory arthritis were prospectively imaged at baseline and 12-months. HR-pQCT scans of the 2nd and 3rd MCP joints and CR of the hands and feet were performed. Joint space width (JSW), total bone mineral density (Tt.BMD), erosion presence and volume were assessed with HR-pQCT. Scan-rescan precision was assessed to define an individual-level least significant change (LSC) criterion. Regression analyses explored prognostic factors for bone damage progression. We observed no significant group-level changes in JSW, Tt.BMD or erosion volume. 20% or fewer joints demonstrated individual-level changes greater than the LSC criterion for mean JSW, Tt.BMD and erosion volume. HR-pQCT detected more erosions than CR in the 2nd and 3rd MCP. Increased symptom duration at diagnosis was weakly associated (P<0.10) with lower JSW minimum and higher JSW standard deviation. Gradual degradation of JSW, proportional to symptom duration, was detected by HR-pQCT. EIA patients need to be closely monitored for exacerbation of arthritis and progression of periarticular bone damage.

Identifiants

pubmed: 32896669
pii: S1297-319X(20)30150-0
doi: 10.1016/j.jbspin.2020.07.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105065

Informations de copyright

Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Scott Cameron Brunet (SC)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Biomedical Engineering Graduate Program and Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary AB, Canada.

Stephanie Finzel (S)

Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Klaus Engelke (K)

Department of Medicine, FAU University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

Steven Kyle Boyd (SK)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Biomedical Engineering Graduate Program and Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary AB, Canada.

Cheryl Barnabe (C)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary AB, Canada.

Sarah Lynn Manske (SL)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Biomedical Engineering Graduate Program and Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary AB, Canada. Electronic address: smanske@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH